TORTUS AI is a technology company.
TORTUS AI has raised $4.0M across 1 funding round.
TORTUS AI has raised $4.0M in total across 1 funding round.
Tortus AI is a UK-based healthcare technology company that builds an AI-powered assistant to automate clinical documentation, enabling clinicians to focus on patient care rather than administrative tasks. Its core product integrates with electronic health record (EHR) systems like EMIS, TPP, and Epic, using medical speech-to-text AI and large language models to transcribe patient conversations in real-time, draft notes, generate referral letters, suggest clinical codes (ICD-10, SNOMED), and support future workflow automations like test ordering.[1][2][4][5]
The platform serves clinicians and healthcare organizations, particularly in UK primary care and NHS settings, solving the problem of time-consuming documentation that burdens doctors—reducing administrative load by up to 25% while emphasizing data privacy (no patient data stored or used for training) and compliance (DTAC, DCB0129, HIPAA, GDPR).[1][3][4][5] Growth momentum includes $4.4M seed funding in 2023 from Khosla Ventures, NHS hospital deployment in Feb 2024 as the first ambient AI with DTAC compliance, partnerships like X-on Health for all UK GPs, and ongoing NHS evaluations with 5000 patients at sites including Great Ormond Street Hospital.[2][3][5]
Tortus AI was founded in 2023 by Dr. Dom Pimenta, a practicing NHS doctor and former lead specialty research physician, and Christopher Tan, an AI expert working on computer-controlling agents, at Europe's leading accelerator Entrepreneur First.[2][4] The idea emerged from a chance meeting where Tan noted doctors' heavy computer work, prompting Pimenta to apply AI to healthcare documentation challenges he faced clinically.[2]
Early traction came quickly: after prototyping and partnering with a top children's hospital, they raised $4.4M seed funding led by Khosla Ventures, hired a multidisciplinary team (one-third clinicians, engineers, AI scientists), achieved NHS DTAC compliance, and launched in a hospital in Feb 2024—reaching revenue in under 12 months.[2] Pivotal moments include pioneering research with Great Ormond Street Hospital, publishing papers on LLM clinical evaluation, and developing CREOLA, the first clinical AI labeling platform for safety validation.[2][4][5]
Tortus AI rides the ambient AI in healthcare trend, automating scribe work amid clinician burnout and staffing shortages, timed perfectly with maturing LLMs and regulatory greenlights like NHS DTAC.[1][2][5] Market forces favoring it include rising EHR adoption, demand for operational efficiency in primary care, and global push for AI compliance post-GDPR/HIPAA evolutions.[3][4]
It influences the ecosystem by setting standards—first DTAC-compliant ambient AI in NHS hospitals, CREOLA for LLM validation, and research partnerships shaping evidence-based medical AI, positioning the UK as a leader while expanding to US via clinician-AI co-working paradigms.[2][4][5]
Tortus AI is poised to scale via NHS primary care rollout (now all GPs via X-on) and international growth, with roadmap features like natural language interfaces, summarization, prescribing, and scheduling automation.[1][2][4] Trends like multimodal AI and federated learning will amplify its model-agnostic edge, while regulatory harmonization boosts adoption; expect influence to grow through more hospital trials and standards-setting, evolving from UK innovator to global clinician co-pilot—redefining care by reclaiming hours for patients.[2][3][5]
TORTUS AI has raised $4.0M in total across 1 funding round.
TORTUS AI's investors include Alliance of Angels, Bold Capital Partners, Khosla Ventures, Anne Wojcicki, Marc Benioff.
TORTUS AI has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in February 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2024 | $4.0M Seed | Alliance of Angels, Bold Capital Partners, Khosla Ventures, Anne Wojcicki, Marc Benioff |